Bioactive glass (type 45S5) nanoparticles: in vitro reactivity on nanoscale and biocompatibility
Source abstract
Abstract
Bioactive glasses represent important biomaterials being investigated for the repair and reconstruction of diseased bone tissues, as they exhibit outstanding bonding properties to human bone. In this study, bioactive glass (type 45S5) nanoparticles (nBG) with a mean particle size in the range of 20–60 nm, synthesised by flame spray synthesis, are investigated in relation to in vitro bioreactivity in simulated body fluid (SBF) and response to osteoblast cells. The structure and kinetics of hydroxyapatite formation in SBF were investigated using transmission electron microscopy (TEM), X-ray diffraction (XRD) and Fourier-transform infrared spectroscopy (FT-IR) revealing a very rapid transformation (after 1 day) of nBG to nanocrystalline bone-like carbonated HAp. Additionally, calcite is formed after 1 day of SBF immersion because of the high surface reactivity of the nBG particles. In the initial state, nBG particles were found to exhibit chain-like porous agglomerates of amorphous nature which are transformed on immersion in SBF into compact agglomerates covered by hydroxyapatite with a reduced size of the primary nanoparticles. In vitro studies revealed high cytocompatibility of nBG with human osteoblast cells, indicated through high lactatedehydrogenase (LDH) and mitochondrial activity as well as alkaline phosphatase activity. Hence, this study contributes to the understanding of the structure and bioactivity of bioactive glass (type 45S5) nanoparticles, providing insights to the phenomena occurring at the nanoscale after immersion in SBF. The results are relevant in relation to the understanding of the nanoparticles’ bioreactivity required for applications in bone tissue engineering.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Antonakos A, Liarokapis E, Leventouri T (2007) Micro-Raman and FTIR studies of synthetic and natural apatites. Biomaterials 28(19):3043–305410.1016/j.biomaterials.2007.02.028 ↗
2. Berner RA (1976) The solubility of calcite and aragonite in seawater at atmospheric pressure and 34.5 0/00 salinity. Am J Sci 276(6):713–73010.2475/ajs.276.6.713 ↗
3. Boccaccini AR, Erol M, Stark WJ, Mohn D, Hong Z, Mano JF (2010) Polymer/bioactive glass nanocomposites for biomedical applications: a review. Compos Sci Technol 70(13):1764–177610.1016/j.compscitech.2010.06.002 ↗
4. Bohner M, Lemaitre J (2009) Can bioactivity be tested in vitro with SBF solution? Biomaterials 30(12):2175–217910.1016/j.biomaterials.2009.01.008 ↗
5. Bosch RF, Adelantado JVG, Moya Moreno MCM (2002) FTIR quantitative analysis of calcium carbonate (calcite) and silica (quartz) mixtures using the constant ratio method. Application to geological samples. Talanta 58(4):811–82110.1016/S0039-9140(02)00372-7 ↗
6. Brunner TJ, Grass RN, Stark WJ (2006) Glass and bioglass nanopowders by flame synthesis. Chem Commun 13:1384–138610.1039/b517501a ↗
7. Bunker BC, Tallant DR, Headley TJ, Turner GL, Kirkpatrick RJ (1988) Structure of leached sodium borosilicate glass. Phys Chem Glasses 29(3):106–120
8. Cerruti M, Morterra C (2004) Carbonate formation on bioactive glasses. Langmuir 20(15):6382–638810.1021/la049723c ↗
9. Cerruti M, Bianchi CL, Bonino F, Damin A, Perardi A, Morterra C (2005a) Surface modifications of bioglass immersed in TRIS-buffered solution. A multitechnical spectroscopic study. J Phys Chem B 109(30):14496–1450510.1021/jp050705t ↗
10. Cerruti M, Greenspan D, Powers K (2005b) Effect of pH and ionic strength on the reactivity of Bioglass® 45S5. Biomaterials 26(14):1665–167410.1016/j.biomaterials.2004.07.009 ↗
11. Curtis AR, West NX, Su B (2010) Synthesis of nanobioglass and formation of apatite rods to occlude exposed dentine tubules and eliminate hypersensitivity. Acta Biomater 6(9):3740–374610.1016/j.actbio.2010.02.045 ↗
12. Danilchenko SN, Kukharenko OG, Moseke C, Protsenko IY, Sukhodub LF, Sulkio-Cleff B (2002) Determination of the bone mineral crystallite size and lattice strain from diffraction line broadening. Cryst Res Technol 37(11):1234–124010.1002/1521-4079(200211)37:11<1234::AID-CRAT1234>3.0.CO;2-X ↗
13. Davies CW, Shedlovsky T (1964) Ion association. J Electrochem Soc 111(3):85C–86C10.1149/1.2426129 ↗
14. Dey A, Bomans PHH, Müller FA, Will J, Frederik PM, de With G, Sommerdijk NAJM (2010) The role of prenucleation clusters in surface-induced calcium phosphate crystallization. Nat Mater 9(12):1010–101410.1038/nmat2900 ↗
15. Du H, Williams CT, Ebner AD, Ritter JA (2010) In situ FTIR spectroscopic analysis of carbonate transformations during adsorption and desorption of CO2 in K-promoted HTlc. Chem Mater 22(11):3519–352610.1021/cm100703e ↗
16. Elliott JC (1994) Structure and chemistry of the apatites and other calcium orthophosphates. Elsevier, Amsterdam
17. Elliott JC, Mackie PE, Young RA (1973) Monoclinic hydroxyapatite. Science 180(4090):1055–105710.1126/science.180.4090.1055 ↗
18. Gabbi C, Cacchioli A, Locardi B, Guadagnino E (1995) Bioactive glass coating: physicochemical aspects and biological findings. Biomaterials 16(7):515–52010.1016/0142-9612(95)91123-G ↗
19. Gann H, Glaspell G, Garrad R, Wanekaya A, Ghosh K, Cillessen L, Scholz A, Parker B, Warner M, Delong RK (2010) Interaction of MnO and ZnO nanomaterials with biomedically important proteins and cells. J Biomed Nanotechnol 6(1):37–4210.1166/jbn.2010.1100 ↗
20. Gerhardt LC, Jell GMR, Boccaccini AR (2007) Titanium dioxide (TiO2) nanoparticles filled poly(d, l lactic acid) (PDLLA) matrix composites for bone tissue engineering. J Mater Sci Mater Med 18(7):1287–129810.1007/s10856-006-0062-5 ↗
21. Hench LL (1991) Bioceramics: from concept to clinic. J Am Ceram Soc 74(7):1487–151010.1111/j.1151-2916.1991.tb07132.x ↗
22. Hench LL (1998) Bioceramics. J Am Ceram Soc 81(7):1705–172810.1111/j.1151-2916.1998.tb02540.x ↗
23. Hench LL, Xynos ID, Polak JM (2004) Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polym Ed 15:543–56210.1163/156856204323005352 ↗
24. Heng B, Zhao X, Xiong S, Ng K, Boey F, Loo J (2011) Cytotoxicity of zinc oxide (ZnO) nanoparticles is influenced by cell density and culture format. Arch Toxicol 85(6):695–70410.1007/s00204-010-0608-7 ↗
25. Ito A, Maekawa K, Tsutsumi S, Ikazaki F, Tateishi T (1997) Solubility product of OH-carbonated hydroxyapatite. J Biomed Mater Res 36(4):522–52810.1002/(SICI)1097-4636(19970915)36:4<522::AID-JBM10>3.0.CO;2-C ↗
26. Jell G, Stevens M (2006) Gene activation by bioactive glasses. J Mater Sci Mater Med 17(11):997–100210.1007/s10856-006-0435-9 ↗
27. Jones JR, Sepulveda P, Hench LL (2001) Dose-dependent behavior of bioactive glass dissolution. J Biomed Mater Res 58(6):720–72610.1002/jbm.10053 ↗
28. Kokubo T (1991) Bioactive glass ceramics: properties and applications. Biomaterials 12(2):155–16310.1016/0142-9612(91)90194-F ↗
29. Kokubo T (1998) Apatite formation on surfaces of ceramics, metals and polymers in body environment. Acta Mater 46(7):2519–252710.1016/S1359-6454(98)80036-0 ↗
30. Kokubo T, Takadama H (2006) How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 27(15):2907–291510.1016/j.biomaterials.2006.01.017 ↗
31. Kokubo T, Ito S, Huang ZT, Hayashi T, Sakka S, Kitsugi T, Yamamuro T (1990) Ca, P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res 24(3):331–34310.1002/jbm.820240306 ↗
32. Koutsopoulos S (2002) Synthesis and characterization of hydroxyapatite crystals: a review study on the analytical methods. J Biomed Mater Res 62(4):600–61210.1002/jbm.10280 ↗
33. Labbaf S, Tsigkou O, Müller KH, Stevens MM, Porter AE, Jones JR (2011) Spherical bioactive glass particles and their interaction with human mesenchymal stem cells in vitro. Biomaterials 32(4):1010–101810.1016/j.biomaterials.2010.08.082 ↗
34. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ (2005) Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 39(23):9370–937610.1021/es051043o ↗
35. Lin S, Van den Bergh W, Baker S, Jones JR (2011) Protein interactions with nanoporous sol–gel derived bioactive glasses. Acta Biomater 7(10):3606–361510.1016/j.actbio.2011.06.042 ↗
36. Loher S (2006) Improved degradation and bioactivity of amorphous aerosol derived tricalcium phosphate nanoparticles in poly(lactide-co-glycolide). Nanotechnology 17(8):205410.1088/0957-4484/17/8/044 ↗
37. Misra SK, Mohn D, Brunner TJ, Stark WJ, Philip SE, Roy I, Salih V, Knowles JC, Boccaccini AR (2008) Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites. Biomaterials 29(12):1750–176110.1016/j.biomaterials.2007.12.040 ↗
38. Mozafari M, Moztarzadeh F, Tahriri M (2010) Investigation of the physico-chemical reactivity of a mesoporous bioactive SiO(2)-CaO-P(2)O(5) glass in simulated body fluid. J Non-Cryst Solids 356(28–30):1470–147810.1016/j.jnoncrysol.2010.04.040 ↗
39. Müller L, Müller FA (2006) Preparation of SBF with different content and its influence on the composition of biomimetic apatites. Acta Biomater 2(2):181–18910.1016/j.actbio.2005.11.001 ↗
40. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8(7):543–55710.1038/nmat2442 ↗
41. Nielsen AE (1984) Electrolyte crystal growth mechanisms. J Cryst Growth 67(2):289–31010.1016/0022-0248(84)90189-1 ↗
42. Ohtsuki C, Aoki Y, Kokubo T, Bando Y, Neo M, Nakamura T (1995) Transmission electron-microscopic observation of glass-ceramic A-W and apatite layer formed on its surface in a simulated body-fluid. J Ceram Soc Jpn 103(5):449–45410.2109/jcersj.103.449 ↗
43. Oyane A, Onuma K, Ito A, Kim HM, Kokubo T, Nakamura T (2003) Formation and growth of clusters in conventional and new kinds of simulated body fluids. J Biomed Mater Res, Part A 64A(2):339–34810.1002/jbm.a.10426 ↗
44. Pan H, Zhao X, Darvell BW, Lu WW (2010) Apatite-formation ability: predictor of “bioactivity”? Acta Biomater 6(11):4181–418810.1016/j.actbio.2010.05.013 ↗
45. Pasteris JD, Wopenka B, Freeman JJ, Rogers K, Valsami-Jones E, van der Houwen JAM, Silva MJ (2004) Lack of OH in nanocrystalline apatite as a function of degree of atomic order: implications for bone and biomaterials. Biomaterials 25(2):229–23810.1016/S0142-9612(03)00487-3 ↗
46. Pichon BP, Bomans PHH, Frederik PM, Sommerdijk NAJM (2008) A quasi-time-resolved cryoTEM study of the nucleation of CaCO3 under Langmuir monolayers. J Am Chem Soc 130(12):4034–404010.1021/ja710416h ↗
47. Rahaman MN, Day DE, Bal BS, Fu Q, Jung SB, Bonewald LF, Tomsia AP (2011) Bioactive glass in tissue engineering. Acta Biomater 7(6):2355–237310.1016/j.actbio.2011.03.016 ↗
48. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR (2006) Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27(18):3413–343110.1016/j.biomaterials.2006.01.039 ↗
49. Sahay G, Alakhova DY, Kabanov AV (2010) Endocytosis of nanomedicines. J Control Release 145(3):182–19510.1016/j.jconrel.2010.01.036 ↗
50. Sepulveda P, Jones JR, Hench LL (2002) In vitro dissolution of melt-derived 45S5 and sol–gel derived 58S bioactive glasses. J Biomed Mater Res 61(2):301–31110.1002/jbm.10207 ↗
51. Shi Z, Huang X, Cai Y, Tang R, Yang D (2009) Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells. Acta Biomater 5(1):338–34510.1016/j.actbio.2008.07.023 ↗
52. Tang R, Henneman ZJ, Nancollas GH (2003) Constant composition kinetics study of carbonated apatite dissolution. J Cryst Growth 249(3–4):614–62410.1016/S0022-0248(02)02332-1 ↗
53. Tilocca A (2011) Molecular dynamics simulations of a bioactive glass nanoparticle. J Mater Chem 21(34):12660–1266710.1039/c1jm11927c ↗
54. Vollenweider M, Brunner TJ, Knecht S, Grass RN, Zehnder M, Imfeld T, Stark WJ (2007) Remineralization of human dentin using ultrafine bioactive glass particles. Acta Biomater 3(6):936–94310.1016/j.actbio.2007.04.003 ↗
55. Waltimo T, Brunner TJ, Vollenweider M, Stark WJ, Zehnder M (2007) Antimicrobial effect of nanometric bioactive glass 45S5. J Dent Res 86(8):754–75710.1177/154405910708600813 ↗
56. Zhu PX, Masuda Y, Yonezawa T, Koumoto K (2003) Investigation of apatite deposition onto charged surfaces in aqueous solutions using a quartz-crystal microbalance. J Am Ceram Soc 86(5):782–79010.1111/j.1151-2916.2003.tb03375.x ↗